News

Filter

Current filters:

Sovaldi

1 to 9 of 59 results

Mylan to distribute Sovaldi and Harvoni in India

23-02-2015

US generics major Mylan said today that its Indian subsidiary has entered into an agreement with Gilead…

Anti-viralsBiotechnologyGileadHarvoniIndiaMarkets & MarketingMylanSovaldi

Médecins du Monde challenges Gilead’s Sovaldi patent in EU

Médecins du Monde challenges Gilead’s Sovaldi patent in EU

11-02-2015

The high price of US biotech major Gilead Sciences’ blockbuster hepatitis C (HCV) drug Sovaldi (sofosbuvir)…

Anti-viralsEuropeGilead SciencesPharmaceuticalPricingSovaldi

Gilead beats 4th-qtr 2014 expectations, as hepatitis C drug sales soar

Gilead beats 4th-qtr 2014 expectations, as hepatitis C drug sales soar

04-02-2015

US biotech firm Gilead Sciences posted fourth-quarter and full-year financial results after markets closed…

Anti-viralsBiotechnologyFinancialGilead SciencesHarvoniSovaldi

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

26-01-2015

US biotech major Gilead Sciences has expanded its hepatitis C generic licensing agreements to include…

Anti-viralsBiotechnologyGenericsGilead SciencesIndiaLicensingSovaldiUSA

Gilead to appeal Indian Patent Office rejection of Sovaldi patent application

Gilead to appeal Indian Patent Office rejection of Sovaldi patent application

19-01-2015

US biotech major Gilead Sciences is to appeal a recent decision by India’s Patent Office to reject…

BiotechnologyGileadIndiaNephrology and HepatologyPatents & Trade marksSovaldi

UK NICE recommends hepatitis C drugs Sovaldi and Olysio

UK NICE recommends hepatitis C drugs Sovaldi and Olysio

16-01-2015

In final draft guidance issued today, England health costs watchdog the National Institute for Health…

Anti-viralsBiotechnologyGilead SciencesJanssenJohnson & JohnsonOlysioPricingRegulationSovaldiUK

Gilead denied patent for hepatitis C drug Sovaldi in India

Gilead denied patent for hepatitis C drug Sovaldi in India

15-01-2015

The Indian Patent Controller yesterday rejected one of US biotech major Gilead Sciences’ key patent…

Anti-viralsBiotechnologyGileadIndiaLegalPatentssofosbuvirSovaldi

CVS to cover Gilead’s hepatitis C drugs Harvoni and Sovaldi exclusively

CVS to cover Gilead’s hepatitis C drugs Harvoni and Sovaldi exclusively

06-01-2015

US pharmacy benefits manager CVS Health has entered into a deal with US biotech major Gilead Sciences…

GileadHarvoniNephrology and HepatologyPharmaceuticalPricingSovaldiUSA

1 to 9 of 59 results

COMPANY SPOTLIGHT

Menarini

Back to top